Vios Compounding (SNF Holdings, LLC), Livonia, MI
Is Vios Compounding (SNF Holdings, LLC) registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Vios Compounding (SNF Holdings, LLC) hold a Michigan pharmacy license?
The Michigan Department of Licensing and Regulatory Affairs lists license 5301012340 for SNF Holdings, LLC, Livonia, status Active, as of Nov 10, 2026. The Colorado State Board of Pharmacy also lists nonresident license OSP 6836 for SNF Holdings LLC, Livonia, MI, status Active, as of Nov 15, 2026. The Illinois Department of Financial and Professional Regulation also lists nonresident license 054019538 for SNF HOLDINGS LLC, LIVONIA, MI, status ACTIVE, as of Nov 13, 2026. The Connecticut Department of Consumer Protection also lists nonresident license PCN.0003304 for SNF HOLDINGS LLC (dba CREAMS N CAPS MICHIGAN), Livonia, MI, status ACTIVE (CURRENT), as of Nov 15, 2026. The Delaware Division of Professional Regulation also lists nonresident license A9-0012557 for SNF Holdings LLC, LIVONIA, MI, status Active, as of Nov 10, 2026.
Has Vios Compounding (SNF Holdings, LLC) had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 untitled letter (Sep 18, 2023), 1 state referral letter (Apr 9, 2024) and 1 FMD-145 letter (Jan 29, 2024) for Vios Compounding (SNF Holdings, LLC). Michigan board disciplinary actions: not checked, because the Michigan Department of Licensing and Regulatory Affairs data this index reads gives license status only and does not include disciplinary actions. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- SNF Holdings, LLC; Vios Compounding
- Location
- Livonia, MI
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 1
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Apr 9, 2024
- FDA Data Dashboard inspections
- 1 inspection: 1 VAI; 1 published Form 483
- Form 483 text on this page
- 1 Form 483, 3 observations
- State board records
- License found: 5301012340, Active
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as SNF Holdings, LLC, (dba Vios Compounding), a 503A facility, with 4 dated actions.
| Document | |||
|---|---|---|---|
| Apr 9, 2024 | State referral letter | Amended State Referral Letter Issued 04/09/2024 | FDA copy (archived) |
| Jan 29, 2024 | FMD-145 letter | FMD-145 Letter Issued 01/29/2024 | Not linked by FDA |
| Sep 18, 2023 | Untitled letter | Untitled Letter Issued 09/18/2023 | FDA copy (archived) |
| Mar 2, 2023 | Form 483 | 483 Issued 03/02/2023 | FDA copy (archived) |
A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists Snf Holdings, LLC, Livonia, MI (FEI number 3021886842), matched to this page by exact name, city and state. It lists 1 inspection: 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Mar 2, 2023 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs) | 3021886842 | 1201524 |
Form 483s FDA has published for this site
- Mar 2, 2023: Form 483 to Snf Holdings, LLC, published Sep 27, 2023. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA’s published Form 483 for this site has 3 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it, with long ones cut and linked to the full form. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.
Inspection Feb 13, 2023 to Mar 2, 2023: 3 observations
- Firm on the cover
- Snf Holdings, LLC, 31035 Schoolcraft Rd, Livonia, MI 48150-2029
- FEI number
- 3021886842
- Establishment type on the cover
- Producer o f Non-Sterile Drug Products
- FDA district office on the cover
- 300 River Place, Suite 5900 Detroit, MI 48207
- Matched to this page by
- FEI number on the cover; linked from actions page, Data Dashboard
- FDA document
- Read the full 483 (PDF on fda.gov)
Observation 1
You produced hazardous drugs without providing adequate segregation, cleaning of work surfaces and cleaning of utensils to prevent cross-contamination.
Specifically,
A. All hazardous and non-hazardous drug products produced onsite use shared production and cleaning equipment; this includes, but is not limited to, the following: biological safety cabinets (BSCs ), capsule machines, analytical balances, electric mortar and pestles, mixing jars, mixing blades, scrub brushes, and utensils. Current cleaning methods do not include the use of deactivating agents after production of hazardous non-sterile drug products.
B. We observed operators routinely touching ancillaiy equipment, such as calculators, keyboards, computer mice, and printers, that contained apparent white powder while producing drug products. These pieces of ancillary equipment are not routinely cleaned and are not product dedicated. For example, the above activities were observed on 02/13/2023 during production of Ivermectin 20 mg capsules lot #02102023@ <Redacted B4> the operator did not change or sanitize gloves between touching different pieces of equipment and proceeded to handle finished capsules. ...
Observation 2
You used a non-pharmaceutical grade component in the formulation of a drug product.
Specifically,
Since 01/01/2021, approximately <Re dacted B4> lots of drug product have been reportedly pro duced using <Re dacted B 4> in the same time period, approximately <Reda cted B4> lots of drug product produced include a component called <Redacted B4>, which is reportedly produced using < Re dacted B 4> . These <Redacted B4> have not been shown to be suitable for use in the production of non-sterile drug products. For example: <R edacted B4> was used to pr oduce N45-GENTA/IBU/ITRA/MUPI/TERB/UREA 0.2/2/1/3/1/20% solution on 02/10/2023 <Reda cted B4> lot <Redacted B4> was produced on 01/19/2023 and was used to produce ketamine nasal spray 100 mg/mL spray lot #02092023@ <Redacted B4>
spray lot #02092023@J
Observation 3
Non-microbial contamination was observed in your production area.
Specifically,
A blue residue was observed along the back edge of the biological safety cabinets (BSCs) used in the production of all capsules made onsite. The blue residue was observed where the stainless-steel top and back white wall of the BSC adjoin. This residue was observed Jo be present during the capsuling of T4/T3 (Biothyroid) SR 300/6 MCG Capsule lot #02142023@ <Redacted B4>. A blue residue was also observed sandwiched between the sides of the stainless-steel top and the glass side wall panel of BSCs used in production of all capsules. This blue residue was observed on multiple days throughout the inspection inside of the BSCs.
State board of pharmacy records
The Michigan Department of Licensing and Regulatory Affairs file dated Nov 10, 2026 lists these licenses under the same name, city and state as this pharmacy. Board file.
| License | Type as the board gives it | Name on the board record | City | Status |
|---|---|---|---|---|
| 5301012340 | Pharmacy | SNF Holdings, LLC | Livonia | Active |
What this covers: LARA’s list gives each license’s status in the department’s words but lists no disciplinary actions, and the department’s disciplinary action reports sit on its website, which refused this index’s automated requests, so Michigan board actions are not checked. The list covers active licenses only (including those the department marks as in late renewal or limited), so a pharmacy with no match may hold a license that is no longer active.
Nonresident licenses in other states
These boards list a nonresident license whose record names this pharmacy’s own name, city and state.
Colorado State Board of Pharmacy, file dated Nov 15, 2026 (Colorado).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| OSP 6836 | OSP | SNF Holdings LLC | Livonia, MI | Active |
Illinois Department of Financial and Professional Regulation, file dated Nov 13, 2026 (Illinois).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| 054019538 | LICENSED PHARMACY | SNF HOLDINGS LLC | LIVONIA, MI | ACTIVE |
Connecticut Department of Consumer Protection, file dated Nov 15, 2026 (Connecticut).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| PCN.0003304 | NONRESIDENT PHARMACY | SNF HOLDINGS LLC (dba CREAMS N CAPS MICHIGAN) | Livonia, MI | ACTIVE (CURRENT) |
Delaware Division of Professional Regulation, file dated Nov 10, 2026 (Delaware).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| A9-0012557 | Non Resident Pharmacy | SNF Holdings LLC | LIVONIA, MI | Active |
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- FDA: FDA Form 483 Frequently Asked Questions
- Michigan Department of Licensing and Regulatory Affairs license file
- Colorado State Board of Pharmacy license file
- Illinois Department of Financial and Professional Regulation license file
- Connecticut Department of Consumer Protection license file
- Delaware Division of Professional Regulation license file
- Delaware Division of Professional Regulation disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.